/

Investors / Denmark / Sunstone Life Science Ventures

Sunstone Life Science Ventures

Venture capital · Copenhagen, Denmark · Europe

sunstone.euTakes pitches from founders

Sunstone Life Science Ventures is an independent European venture capital investment firm founded in 2007. It invests in early-stage life science companies developing novel therapeutics for humans and works hands-on with portfolio companies on funding and business development.

Invests inHealthcare & Biotech

In its own wordslife sciencestherapeuticsbiotechhealthcaredrug development

Your fit with Sunstone Life Science Ventures

Four questions about your startup

See how your round matches what it backs, point by point.

Or find every investor that fits
24portfolio companies
2funding rounds on record
2rounds, last 12 months
$100M or moretypical round it comes in at
Series Amost frequent entry
EuVECA fund registered with Finanstilsynet, no longer activelatest fund

Sunstone Life Science Ventures lists 24 checked portfolio companies on its own site and is named in 2 funding rounds. Its most frequent entry is Series A, 100% of the companies with a known first round. Its largest themes are Healthcare & Biotech (95%) and Food & Agriculture (5%). It invests most often alongside Kurma Partners, Ysios Capital and Avoro Capital Advisors.

Counts come from funding rounds that name Sunstone Life Science Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.

Round figures show recent activity, not Sunstone Life Science Ventures' whole history. Rounds on record name 2 companies; its own site lists 24. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.

Entry stage

share of companies by the stage of its first round
Show as a table
Share of companies by the stage of the firm's first round
Value
Pre-seed0%
Seed0%
Series A100%
Series B0%
Growth0%

Activity by year

rounds it joined, last 10 years
Show as a table
Funding rounds per year
TotalRounds it led
'1700
'1800
'1900
'2000
'2100
'2200
'2300
'2400
'2510
'2610

Investor profile

percentile among all firms
Portfolio size: 24 companiesRecent activity: 2 rounds in 12 monthsEarly stage: 0% of entries at pre-seed or seedEvidence: 4% of companies confirmed by a roundSector focus: 95% in its largest sectorReach: 9 countriesPortfolio size59th pctRecent activity69th pctEarly stage54th pctEvidence61th pctSector focus97th pctReach93th pct
This firmMedian of all firms
Show as a table
Sunstone Life Science Ventures compared with all firms
MeasurePercentile of all firmsValue
Portfolio size59th24 companies
Recent activity69th2 rounds in 12 months
Early stage54th0% of entries at pre-seed or seed
Evidence61th4% of companies confirmed by a round
Sector focus97th95% in its largest sector
Reach93th9 countries

Invests most often with

firms sharing its portfolio companies
Show as a table
Co-investors
Share
Kurma Partners5
Ysios Capital3
Avoro Capital Advisors2
Industrifonden2
Omega Funds2
ALS Investment Fund1
AMR Action Fund1
AdBio partners1

All co-investors

Its portfolio companies

where they are based, and what their own sites show

Headquarters

Site status

  • Site answers2396%
  • No longer answers00%
  • Points to another company14%
  • Parked or sold domain00%

A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.

Investment themes

share of its checked companies

This firmAll checked companies

Show as a table
Investment themes
This firmAll checked companies
Healthcare & Biotech95%15%
Food & Agriculture5%3%

Compare Sunstone Life Science Ventures head to head

portfolio size, rounds, entry stages, themes and the companies both back

Three or more firms at once: portfolio overlap.

Funds

from public registers and its site
Kommanditselskabet af 26. juni 2017EuVECA fund registered with Finanstilsynet, no longer active, ESMA register

Recent portfolio activity

when companies last raised with Sunstone Life Science Ventures
DateCompanyStage
19 Aug 2026Kynexiskynexistx.comSeries A
1 Dec 2025Targedtargedbiopharmaceuticals.comSeries A

Round details for Sunstone Life Science Ventures

Amounts, full round histories and every co-investor in Sunstone Life Science Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.

See rounds on Fundup AI →

Portfolio

24 companies checked against their own sites
CompanyWhat it doesThemesFirst round with itEvidence
Acarixacarix.com · GermanyAcarix develops and markets a point-of-care diagnostic aid that uses acoustics and computational processing to analyze coronary blood flow and risk of significant coronary stenosis.
Healthcare & Biotech
Portfolio page
Alligator Biosciencealligatorbioscience.se · SwedenAlligator Bioscience is a biotech company that has previously focused on tumor-directed immunoncology and now prioritizes its economic interest in HLX22, a HER2 antibody being developed by Shanghai Henlius Biotech, and seeks to outlicense or divest mitazalimab.
Healthcare & Biotech
Portfolio page
Arcomaarcoma.se · SwedenArcoma develops, produces and provides complete digital radiography and radiology solutions worldwide.
Healthcare & Biotech
Portfolio page
Asceliaascelia.com · SwedenAscelia develops drugs for cancer treatment
Healthcare & Biotech
Portfolio page
Cantargiacantargia.com · SwedenThe company develops antibody-based medicines targeted at IL1RAP to treat cancer and autoimmune and inflammatory diseases.
Healthcare & Biotech
Portfolio page
DiogenXdiogenx.com · FranceDiogenX is a preclinical stage biotech company committed to discovering and developing innovative biologics as new therapeutics options for diabetic patients.
Healthcare & Biotech
Portfolio page
Egaletegalet.com · United StatesEgalet is a fully integrated specialty pharmaceutical company focused on developing effective medicines for patients with acute and chronic pain
Healthcare & Biotech
Portfolio page
Evolvaevolva.com · SwitzerlandEvolva makes products and registrations and has financial statements available
Food & Agriculture
Portfolio page
F2Gf2g.com · United KingdomF2G develops therapeutics for rare fungal infections
Healthcare & Biotech
Portfolio page
IO Biotechiobiotech.comIO Biotech develops therapeutic cancer vaccines
Healthcare & Biotech
Portfolio page
Jenavalve Technologyjenavalve.comJenavalve Technology develops and manufactures a transcatheter aortic valve replacement system for aortic regurgitation
Healthcare & Biotech
Portfolio page
Kynexiskynexistx.com · Netherlands
Aug 2026Series AFunding round
MinervaXminervax.com · DenmarkMinervaX is developing a prophylactic vaccine against Group B Streptococcus
Healthcare & Biotech
Portfolio page
Neumirnaneumirna.com · DenmarkNeumirna Therapeutics develops miRNA-based therapies for neurological diseases
Healthcare & Biotech
Portfolio page
Orphazymeorphazyme.com · DenmarkThe company engages in activities and investments related to biopharmaceutical research and development
Healthcare & Biotech
Portfolio page
OxTheraoxthera.com · SwedenOxThera develops novel treatment options for rare kidney diseases, specifically primary hyperoxaluria.
Healthcare & Biotech
Portfolio page
Rewind Therapeuticsrwdtx.com · BelgiumRewind Therapeutics develops first-in-class therapeutics designed to re-initiate the process of remyelination in patients suffering from major debilitating diseases
Healthcare & Biotech
Portfolio page
Symphogenserviersymphogen.com · DenmarkThe company advances superior mAb therapeutics to improve the lives of cancer patients
Healthcare & Biotech
Portfolio page
STEP Pharmastep-ph.com · FranceSTEP Pharma is developing a novel drug called dencatistat for the treatment of cancer
Healthcare & Biotech
Portfolio page
Synendos Therapeuticssynendos.com · SwitzerlandSynendos develops new therapies to treat neuropsychiatric disorders
Healthcare & Biotech
Portfolio page

About this data

site last read 5 Nov 2026
The homepage of Sunstone Life Science Ventures, as last read
sunstone.eu as VCinfo last read it
Site
sunstone.eu
Last read
5 Nov 2026
Watching since
5 Nov 2026
Rounds since
1 Dec 2025
Companies checked
24

Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.

How we grade the data

Free account · no card

Get Sunstone Life Science Ventures' profile as data

Pull Sunstone Life Science Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.

Work email, sign-in link by email. Already have an account? Log in
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/firms/sunstone.eu

# also
GET /v1/firms/sunstone.eu/portfolio
GET /v1/firms/sunstone.eu/coinvestors
GET /v1/firms/sunstone.eu/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing